Invasive fungal infections in the oncology patient: an overview of clinical manifestations and treatment.
This session addressed the different types of fungal infections and their risks seen in patients with cancer. The history of treatments used as well as new treatments, including those just approved and those still on the horizon, were covered. Risks and indications for the drugs also were discussed.
D000208:Acute Disease; D000935:Antifungal Agents / Q000145:classification / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology; D009369:Neoplasms / Q000150:complications* / Q000276:immunology; D018579:Patient Selection; D012307:Risk Factors
D000935:Antifungal Agents